Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Negative ana"'
Autor:
Shuangxi Li, Qi Bian
Publikováno v:
Clinical Case Reports, Vol 11, Iss 11, Pp n/a-n/a (2023)
Key Clinical Message Systemic lupus erythematosus is difficult to diagnose in patients who are antinuclear antibody (ANA) negative and lack typical clinical manifestations. For such patient who presented ANA‐negative severe lupus‐like manifestati
Externí odkaz:
https://doaj.org/article/6655e1718c5143fb98c9b441e9110f47
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cureus
Hydralazine induced lupus syndrome (HILS), a form of Drug-Induced Lupus (DIL), was first reported in 1953. Since then, studies have shown an increasing incidence of HILS. It presents with lupus-like symptoms such as arthralgia, fever, chest pain, ano
Publikováno v:
European Journal of Rheumatology
Up to 10% of systemic lupus erythematosus (SLE) cases are drug-induced; hence, they are called drug-induced lupus syndrome (DILS). Antinuclear antibody (ANA) should be present to diagnose SLE and DILS. ANA-negative lupus is very rare; therefore, it p
Autor:
H.J.L. Beaart, Rory C Monahan, César Magro Checa, L. J. J. Beaart van de Voorde, Maka Gegeneva, Gerda M Steup-Beekman, E.G. Brilman, Thomas Huizinga
Publikováno v:
Poster Presentations.
Background New ACR-EULAR SLE criteria have been proposed in order to attempt to improve classification for clinical and translational research (1, 2). Objectives We evaluated the performance of the proposed 2017 ACR-EULAR classification criteria in a
Autor:
Jorge Sanchez-Guerrero, David I. Daikh, Dimitrios T. Boumpas, Ricard Cervera, Falk Hiepe, Elena Massarotti, Dafna D. Gladman, Josef S Smolen, Diane L. Kamen, David Wofsy, Karen H. Costenbader, David Jayne, Dinesh Khanna, Nathalie Costedoat-Chalumeau, Rosalind Ramsey-Goldman, Marta Mosca, Bevra H. Hahn, Sindhu R. Johnson, Martin Aringer, Thomas Dörner
Publikováno v:
The Journal of rheumatology. 46(7)
Objective.Given the complexity and heterogeneity of systemic lupus erythematosus (SLE), high-performing classification criteria are critical to advancing research and clinical care. A collaborative effort by the European League Against Rheumatism and
Autor:
Melanie Hahn, Christopher Krause, Kathleen Mallet, Kai Fechner, Joyce J. B. C. van Beers, Wymke Hormann, Johanna Fraune, Jan Damoiseaux
Publikováno v:
Autoimmunity Highlights, 9:8. Springer Verlag
PurposeIndirect immunofluorescence (IIF) on the human epithelial cell-line HEp-2 (or derivatives) serves as the gold standard in antinuclear antibody (ANA) screening. IIF, and its evaluation, is a labor-intensive method, making ANA testing a major ch
Publikováno v:
THURSDAY, 14 JUNE 2018.
Objectives To investigate the expression of miRNAs-146a and −499 and their polymorphisms in Egyptian patients with RA and to evaluate their relationship to clinical manifestations and disease activity. Methods Fifty-two RA patients and 56 matched c
Autor:
Jinoos Yazdany, Joel M. Hirsh, JoAnn Zell, Lisa A. Davis, Barbara Goldstein, Angela Keniston, Vivian Tran, Amy Storfa
Publikováno v:
The Open Rheumatology Journal
The open rheumatology journal, vol 9, iss 1
The open rheumatology journal, vol 9, iss 1
Objective:In 2013, the American College of Rheumatology (ACR) participated in the Choosing Wisely campaign and devised a recommendation to avoid testing antinuclear antibody (ANA) subserologies without a positive ANA and clinical suspicion of disease
Publikováno v:
RMD Open
Introduction Visual evaluation of indirect immunofluorescence (IIF) on human epithelial-2 cells is the routine method for screening for antinuclear antibodies (ANA) in connective tissue diseases. Since visual IIF is time-consuming and subjective, aut